Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
5.59 Up 0.05(0.90%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2013Jun 30, 2012Jun 30, 2011
Total Revenue 16,999   -   10,622  
Cost of Revenue -   -  1,347  
Gross Profit 16,999   -   9,275  
Operating Expenses
Research Development8,401  8,042  8,801  
Selling General and Administrative3,372  4,323  5,397  
Non Recurring6,205   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (979) (12,489) (5,043)
Income from Continuing Operations
Total Other Income/Expenses Net1,001  331  (972)
Earnings Before Interest And Taxes22  (12,158)(6,015)
Interest Expense -  1  1  
Income Before Tax22  (12,159)(6,016)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops22  (12,159)(6,016)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 22   (12,036) (5,895)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 22   (12,036) (5,895)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.